Milroy disease is a rare, lifelong form of primary lymphedema that usually shows up at birth or in early childhood with swelling in one or both legs and feet, and sometimes the toes or genitals. The swelling happens because the lymph vessels don’t form or work normally, so fluid builds up under the skin; doctors describe this as chronic lymphedema. Many living with Milroy disease also have thickened skin over time, small skin bumps called papillomas, and a tendency toward skin infections in the swollen area, but not everyone will have the same experience. It affects all genders; most cases are inherited in families, though some start as a new gene change, and while life expectancy is generally near normal, complications can occur without good skin care and infection prevention. Treatment focuses on managing swelling and protecting the skin—compression garments, exercise, limb elevation, careful skin care, and specialized physical therapy are the mainstays; surgery is considered in select cases.
How many people live with Milroy disease?
Milroy disease is very rare. As of 2023, published estimates suggest about 1 to 9 people per 1,000,000 have it, which works out to roughly 8,000 to 70,000 people worldwide. Using the same rate for the 2023 U.S. population suggests about 300 to 3,000 people in the United States; these are approximate estimates, not direct counts.
Overview
Milroy diseaseSymptoms
Early signs of Milroy disease are painless swelling in one or both feet and lower legs, usually from birth or infancy. Other features include heaviness, thickened skin, prominent veins, toenail changes, and skin infections; boys can develop a hydrocele.
Outlook and prognosis
Most people with Milroy disease live a normal lifespan. Swelling often begins early and can be steady or slowly progress, but careful lifelong care—skin protection, compression, exercise, and prompt infection treatment—helps control symptoms and prevent complications. Regular follow-up supports long-term comfort and mobility.
Causes and risk factors
Milroy disease results from inherited changes in the FLT4 (VEGFR3) gene that disrupt lymphatic development. It follows an autosomal-dominant pattern; family history is the main risk, though new variants can occur. Infections, injury, and obesity may worsen severity or complications.
Genetic influences
Genetics is central in Milroy disease. Most cases result from inherited changes in the FLT4/VEGFR3 gene that disrupt lymphatic development; a single altered copy is enough. Variants can arise de novo, and severity can vary even within families.
Diagnosis
Doctors suspect Milroy disease from lifelong leg swelling and family history. Diagnosis is confirmed by clinical features plus lymphatic imaging and, when available, genetic tests. Discussing genetic diagnosis of Milroy disease with a specialist can guide care.
Treatment and drugs
Treatment for Milroy disease focuses on reducing lifelong limb swelling and preventing skin problems. Many benefit from compression garments, manual lymphatic drainage, exercise, and meticulous skin care; some need intermittent pneumatic pumps. Selected cases consider procedures like lymphatic bypass or debulking surgery.
Symptoms
Swelling in one or both legs from birth or soon after is the most noticeable change. Early on, this might look like baby socks leaving deep marks or shoes feeling snug by late afternoon. These early features of Milroy disease mainly affect the feet, ankles, and lower legs and may become more obvious with standing, heat, or growth spurts. Skin and nail changes, infections, and in some boys and men, scrotal swelling, can also occur.
Persistent swelling in one or both legs from birth or early infancy. The tops of the feet, ankles, and lower legs look puffy and may feel heavy by day’s end. Swelling can be worse with heat or long standing.
The top of the foot can look square or full, with deeper creases around the toes and ankles. Finding comfortable shoes or boots may take trial and error. This feature is common in Milroy disease.
Early swelling may feel soft and leave a brief dent when pressed. Over time it can feel firmer or rubbery. This shift reflects long-standing lymph fluid buildup.
Toenails can appear thick, wide, or slightly upturned. Ingrown nails or nail breakage may happen more often. Trimming and roomy footwear can help protect the nails.
How people usually first notice Milroy disease?
Many families first notice the first signs of Milroy disease soon after birth when a baby’s feet and lower legs look persistently swollen, sometimes with thicker skin or visible veins that don’t fade with elevation. Doctors often confirm suspicion during early checkups by finding non-pitting lymphedema (swelling that feels firm rather than leaving a dent) limited to the legs, and they may look for associated features like upturned toenails or small wart-like skin changes. In some cases, how Milroy disease is first noticed is through a family history of similar leg swelling, which prompts early evaluation of the newborn and, if needed, genetic testing of the FLT4/VEGFR3 gene.
Types of Milroy disease
Milroy disease is a genetic condition where people are born with, or develop early, long‑lasting swelling (lymphedema), usually in the legs. It stems most often from changes in the FLT4 gene, which affects how lymph vessels form and drain fluid. There aren’t multiple named clinical subtypes the way some conditions have; instead, differences come from which variant in the gene runs in a family and how strongly it affects lymph vessel growth. Not everyone will experience every type.
Classic early-onset
Swelling appears at birth or in the first year, most often in both lower legs and feet. Skin may look thicker over time, and toenail changes can develop. Growth and development are otherwise typical.
FLT4-confirmed familial
A disease-causing FLT4 variant is found in the family, with several relatives affected. Symptoms don’t always look the same for everyone, so some relatives have mild ankle swelling while others have more pronounced leg edema. Hand involvement is less common but can occur.
Sporadic presentation
No other relatives are known to be affected, even though symptoms match Milroy disease. Genetic testing may still find an FLT4 change, but sometimes no variant is detected. Care focuses on managing lifelong leg swelling.
Variable severity spectrum
Some have mild, activity‑related puffiness that improves with elevation, while others develop persistent, fibrotic swelling. Doctors sometimes classify symptoms as mild versus moderate–severe to guide compression and therapy. The balance of symptoms can shift over time.
Associated features
A smaller group develops papillomas on the skin, prominent veins, or toenail changes in addition to leg swelling. These features tend to track within families and can help confirm the diagnosis. Eye or organ involvement is not typical in types of Milroy disease.
Can I slow down the onset of symptoms?
There’s no proven way to delay when symptoms of Milroy disease start; most people who inherit it have leg swelling from birth or early childhood because the body’s drainage vessels for lymph fluid did not form normally before birth. Still, you may lower the chance of flare-ups and complications by keeping a healthy weight, staying moderately active, caring for skin and nails to prevent infections, protecting legs from injury and excess heat, and using compression under a clinician’s guidance if swelling appears. These steps won’t prevent the disease, but they can help manage symptoms and support day‑to‑day comfort.
What genetics can tell you about symptoms
In Milroy disease, changes in the FLT4/VEGFR3 gene disrupt lymphatic vessel growth, leading to firm, nonpitting swelling (lymphedema) of the feet and legs from birth or early infancy. Some also develop toe swelling, upturned toenails, papillomas, or recurrent skin infections.
Causes and risk factors
Milroy disease is usually caused by a change in the FLT4 gene (also called VEGFR3) that disrupts how lymph vessels form and drain fluid. This change is most often inherited in an autosomal dominant way—if one parent carries it, each child has a 50% chance of inheriting it—but it can also arise for the first time in a child with no family history.
The main risk factor for Milroy disease is having a close relative with the FLT4 gene change, though the same change can affect family members differently. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Environment and lifestyle don’t cause Milroy disease, but heat, long periods of standing or sitting, tight clothing, weight gain, pregnancy, and skin infections can worsen swelling; regular movement, compression, leg elevation, and careful skin care may reduce flare-ups and complications.
What are the most common causes or risk factors?
Milroy disease is most often caused by a change in a single gene called FLT4, which helps lymph vessels develop; this change is usually inherited from a parent, so each child of an affected parent has about a 1 in 2 (50%) chance of having it, though it can also appear for the first time in a family. The strongest risk factor is a family history of the condition or carrying this gene change. There are no known lifestyle or environmental causes, although infections, injuries, heat, or long periods of standing can temporarily make swelling worse in people who have it.
Environmental and biological risk factors
Milroy disease begins very early in development, so most influences are set before birth. Because early symptoms of Milroy disease often appear at or soon after birth, studies have not found clear links with later pregnancy exposures or delivery events. Researchers are still exploring how outside influences interact with our inner biology. Below are the environmental and biological factors currently known—or not known—to affect the chance of this condition.
Milroy disease arises from differences that occur early in how lymph vessels form. These changes are present before birth and are not known to be driven by outside exposures.
Research has not shown a consistent link between older maternal or paternal age and Milroy disease. Current evidence does not suggest higher risk in older parents.
Common pregnancy conditions like diabetes or high blood pressure have not been tied to higher risk of Milroy disease. No specific maternal illness has been confirmed to cause it.
Typical viral or bacterial infections during pregnancy have not been shown to increase risk. Severe infections are not known to trigger this condition.
Genetic risk factors
In most families, Milroy disease traces back to a change in a single gene that guides how lymph vessels form and mature. The main gene involved is FLT4, which makes the VEGFR3 protein; a faulty copy can interfere with lymph drainage from birth. Carrying a genetic change doesn’t guarantee the condition will appear. Knowing your family history can help you spot early symptoms of Milroy disease in a newborn and seek care promptly.
FLT4 gene variants: Most confirmed cases of Milroy disease are caused by changes in FLT4, which directs signals through the VEGFR3 protein. These changes hinder the growth and function of small lymph vessels, leading to lifelong swelling that usually begins at or soon after birth.
Autosomal dominant: A single altered copy of the gene can be enough to cause Milroy disease. Each child of an affected parent has a 50% chance of inheriting the variant and the risk of lymphedema.
De novo changes: Sometimes the FLT4 variant arises for the first time in a child, with no prior family history. Parents typically test negative, and the chance of it happening again in another child is generally low.
Variable expression: The same genetic change can lead to different levels of swelling between relatives. Some have mild, barely noticeable changes, while others need ongoing care from infancy.
Incomplete penetrance: Not everyone who inherits the variant will show clear signs. This helps explain why a family member can carry the change yet have no obvious lymphedema.
Other rare genes: A small number of families with Milroy-like lymphedema do not have FLT4 changes. Rare variants in genes involved in lymph growth, such as VEGFC, have been reported, but they account for only a minority of cases.
Family history: Having a parent or close relative with Milroy disease increases the chance of being affected. Mapping who is affected across generations can clarify whether a dominant pattern is present.
Genetic testing: Sequencing FLT4 can confirm the cause in many families and support counseling about future pregnancies. Broader panels for primary lymphedema genes may be used when FLT4 testing is negative.
Lifestyle risk factors
Swelling in the legs can make daily routines—like standing at work or walking the dog—feel heavier than they should. People often ask about lifestyle risk factors for Milroy disease, and the short answer is that habits don’t cause it but can change how much swelling you face or how often infections show up. Genes may set the foundation, but environment builds the house. The choices below focus on how lifestyle affects Milroy disease, especially the day‑to‑day swelling and skin health many live with.
Too little movement slows the calf-muscle “pump” that helps move lymph fluid upward. Gentle, regular activity can improve flow and reduce heaviness.
Extra weight can add pressure on lymph vessels and worsen leg swelling. Gradual weight loss may ease symptoms and make compression more effective.
Salty foods can pull in extra fluid and add to swelling. Choosing lower-salt options may help legs feel lighter by the end of the day.
Staying in one position lets fluid pool in the lower legs. Breaking up long stretches with brief walks or ankle pumps can ease buildup.
Risk prevention
Milroy disease is a genetic form of lifelong lymphedema, so you can’t prevent the condition itself, but you can lower complications and flares. Day-to-day care focuses on protecting the skin, keeping swelling controlled, and catching infections early. Prevention works best when combined with regular check-ups. Plans are tailored to age, affected limbs, and how severe the swelling is.
Keep skin clean and well moisturized to reduce cracking that invites infection. Treat cuts, insect bites, and rashes quickly and watch for redness or warmth.
Use properly fitted wraps or stockings to help move fluid and limit swelling. A lymphedema therapist can guide the right type and fit for Milroy disease.
Regular gentle activity, like walking or swimming, helps muscle pumping to move lymph. Avoid overstraining; start slowly and build up as tolerated.
Elevate the affected limb above heart level when resting to ease fluid build-up. Short, frequent breaks with elevation can help throughout the day.
Can you prevent Milroy disease?
You can’t prevent Milroy disease, because it’s usually caused by an inherited change in a gene that starts before birth. If it runs in your family, a genetic counselor (a specialist who explains inherited conditions and testing options) can help you understand the chance of passing it on and discuss options such as testing before or during pregnancy. For people living with it, steps like good skin care, staying active, and keeping a healthy weight can lower infections and swelling, but they don’t prevent the condition itself.
Transmission
Milroy disease is not infectious and cannot be spread by touch, coughing, sex, or shared items.
Most often, Milroy disease is inherited in an autosomal dominant way, meaning a change in just one copy of the gene can cause it, and each child of a parent with Milroy disease has a 50% chance of inheriting it. Severity can vary widely within the same family, and some people with the gene change may have few or no symptoms. Sometimes Milroy disease appears for the first time in a family due to a new genetic change; in that situation, the parents typically do not have the gene change, and the chance of it happening again is usually lower. If you’re wondering how Milroy disease is inherited in your family, a genetic counselor can explain the genetic transmission of Milroy disease and discuss your specific risks.
When to test your genes
Consider genetic testing if you were born with persistent leg swelling, have a family history of Milroy disease, or developed unexplained, early-onset lymphedema. Testing can confirm the diagnosis, guide preventive care for infections and skin health, and inform tailored compression, exercise, and monitoring plans. It also helps relatives understand their own risks and options.
Diagnosis
Milroy disease is usually identified through its pattern of lifelong swelling that often starts at birth or in early infancy, and then confirmed with targeted tests. Doctors confirm the genetic diagnosis of Milroy disease with genetic testing after a clinical exam suggests it. Getting a diagnosis is often a turning point toward answers and support. Because other conditions can also cause leg or foot swelling, the process focuses on recognizing telltale features and ruling out more common causes first.
Providers look for swelling of the feet and lower legs that begins at birth or early in life. Changes like thickened skin, prominent veins, or toenail changes can support the diagnosis. A history of scrotal swelling (hydrocele) in boys may also be a clue.
The exam focuses on where the swelling appears, whether it pits with pressure, and any skin or nail changes. Doctors also check both sides for a similar pattern and look for signs of infection.
A pattern of similar swelling in close relatives can point to an inherited cause. Even within a family, symptoms can range from mild to more noticeable.
Tape or device-based measurements track leg and foot size over time. This helps document persistent swelling and distinguish it from short-term fluid shifts.
How is Milroy disease diagnosed?
Doctors usually diagnose Milroy disease by noting lifelong swelling of the feet and lower legs that begins at birth or soon after, checking for a family pattern, and doing a careful exam for typical skin and nail changes. They may order tests to rule out other causes and to see how lymph fluid is moving, such as an ultrasound of the veins and special imaging that traces lymph flow. Genetic testing to look for a change in a gene that guides lymph vessel growth can support the diagnosis and help with family planning, but not everyone has a detectable change, so doctors often make the diagnosis from the history and exam.
Stages of Milroy disease
Milroy disease does not have defined progression stages. It’s a lifelong form of primary lymphedema that shows up differently from person to person—early symptoms of Milroy disease often include swelling in the feet and lower legs that may stay fairly steady or slowly worsen, with flare-ups during growth spurts, long travel, hot weather, or infections. Different tests may be suggested to help confirm the diagnosis and gauge severity, such as a physical exam with limb measurements (centimeters/inches), skin and nail checks, family history review, imaging of the lymph system, and sometimes genetic testing for FLT4/VEGFR3 changes. Ongoing monitoring usually involves periodic measurements, watching for skin infections, and reviewing how well compression and self-care are controlling swelling.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many people with Milroy disease live a normal lifespan, but day-to-day management matters. Swelling in the legs and feet often starts early and can persist, which may affect walking, shoe fit, and comfort during travel or hot weather. Infections like cellulitis are the main medical risk; repeated episodes can scar lymph vessels and worsen swelling over time. Early care can make a real difference, especially when it comes to preventing skin breakdown and treating infections quickly.
The outlook is not the same for everyone, but many living with Milroy disease find a steady pattern rather than rapid change. Some people notice stable, manageable swelling with good compression and skin care, while for others the affected area slowly expands or becomes firmer. Serious complications are uncommon with consistent care, and mortality from Milroy disease itself is low; most health concerns relate to infection, reduced mobility, or, rarely, blood clots. If you’re watching for early symptoms of Milroy disease in a child, prompt referral to a lymphedema clinic can set up lifelong habits that protect skin and lymph flow.
Understanding the prognosis can guide planning and help you stay ahead of flares. With ongoing care, many people maintain work, school, sports, and family life, adjusting routines as needed for compression garments, exercise, and travel plans. Pregnancy, surgery, or long flights may temporarily increase swelling, but preventive steps—well-fitted compression, movement breaks, good hydration, and early antibiotics when indicated—help reduce risk. Talk with your doctor about what your personal outlook might look like, including how your medical history, body weight, activity level, and any genetic findings might shape the course over time.
Long-term effects
Milroy disease is a lifelong form of primary lymphedema, so the main effects relate to fluid buildup and how tissues respond over time. Long-term effects vary widely, and severity can shift with growth, hormones, weight changes, or infections. Many live a full lifespan, with challenges focused on limb swelling, skin health, and comfort in daily movement. Doctors often describe these as long-term effects or chronic outcomes.
Swelling of the feet and lower legs tends to be present from infancy and continues through life. It may be stable for years or gradually increase, often differing from one leg to the other. Many people with Milroy disease notice heavier, tighter limbs by the end of the day.
Long-standing swelling can thicken the skin and make it feel firm or rubbery. Small warty bumps and skin folds may appear over time, especially on the feet and ankles. These changes increase friction and can irritate the skin.
The swollen limb is more prone to skin infections like cellulitis. Infections can come on quickly with redness, warmth, and pain, and may leave the limb more swollen afterward. Preventing breaks in the skin can lower this risk, but the tendency often persists.
Toenails may look upturned, thick, or ridged, and the toes can appear square. The top of the foot may stay puffy, and ankle bones may be less visible. These foot shape changes can make shoes feel tight or uneven.
How is it to live with Milroy disease?
Living with Milroy disease often means planning around chronic leg swelling that can flare with heat, long flights, or standing for hours. Many notice heaviness, aching, or tight skin by day’s end and build routines that help—compression garments, elevating legs, gentle exercise, skin care to prevent infections, and pacing activities. Socially, visible swelling or the need for compression can draw questions, but clear explanations and supportive circles make a difference; family and friends often help with practical tasks and encouragement during flares or infections. With consistent habits and regular medical follow-up, many lead active lives while keeping complications—like cellulitis and discomfort—at bay.
Treatment and drugs
Treatment for Milroy disease focuses on easing swelling, protecting skin, and preventing infections. Supportive care can make a real difference in how you feel day to day. Daily measures often include compression garments, gentle exercise, leg elevation, and meticulous skin care to lower the risk of cellulitis; doctors may prescribe antibiotics promptly if infections occur. Some people benefit from specialized therapies such as manual lymphatic drainage or pneumatic compression, and in select cases, surgery (like lymphatic bypass or debulking procedures) may be considered to reduce severe swelling or improve function. Ask your doctor about the best starting point for you, and review your plan regularly since needs can change over time.
Can you cure Milroy disease?
There’s currently no cure for Milroy disease. Treatment can’t fix the underlying cause, but it can control swelling and lower the risk of skin infections—using compression stockings or wraps, gentle massage, exercise, good skin care, and sometimes devices or surgery to help move fluid. With steady care, many people keep symptoms manageable and protect limb function over the long term.
Non-drug treatment
Living with Milroy disease often means managing lifelong limb swelling so you can stay active and comfortable. Non-drug treatments often lay the foundation for day-to-day control, helping move lymph fluid, protect skin, and prevent flare-ups. With consistent routines and guidance from a lymphedema therapist, many people keep swelling steadier and reduce complications.
A trained therapist combines manual lymph drainage, compression, exercise, and skin care. This structured program is tailored to your limb size and daily life. It is often the cornerstone for Milroy disease care.
Fitted sleeves, stockings, or custom flat-knit pieces help prevent fluid from pooling. They are worn during the day and sometimes at night as advised. Re-measure regularly because limb size can change.
Gentle, skin-stretching strokes help direct fluid toward healthy lymph pathways. Sessions may be done by a certified therapist and taught for home use. This can ease heaviness and improve limb shape in Milroy disease.
Walking, swimming, and light strength work use muscle “pumps” to move lymph. Aim for regular, low-impact activity while wearing compression. Start slowly and increase as tolerated to avoid overuse swelling.
Your genes may have an impact on how drugs work for you
Medicines for Milroy disease, like diuretics for swelling or antibiotics for skin infections, can work differently depending on genes that affect drug processing and immune responses. Genetic differences may change dose needs, side‑effect risks, and who benefits most.
Pharmacological treatments
Most medicines used in Milroy disease focus on preventing and treating skin infections and easing discomfort, since drugs don’t directly drain lymph fluid yet. Medication is often just one chapter alongside compression, skincare, and infection prevention. Some options are standard, while others are specialist or off-label and reserved for select situations. Your care team will tailor choices to your history and any other health conditions.
Cephalexin, dicloxacillin, or amoxicillin–clavulanate are common first choices; clindamycin is an option if allergic to penicillin. Because swelling can hide early symptoms of Milroy disease skin infection, starting antibiotics promptly helps prevent complications. Treatment usually lasts about 5–7 days, guided by medical review.
Low-dose penicillin V (phenoxymethylpenicillin) or benzathine penicillin G may be used to prevent repeat infections; erythromycin or azithromycin can be alternatives if penicillin isn’t suitable. Doctors often consider this after two or more cellulitis episodes in a year. Duration is individualized, commonly 6–12 months, with regular reassessment.
Clotrimazole or terbinafine creams help clear athlete’s foot between the toes, lowering cellulitis risk. Apply as directed (often once or twice daily) and continue for about a week after the skin looks normal. Keeping skin dry and intact boosts the benefit.
Acetaminophen (paracetamol) or ibuprofen can ease pain and fever during infection flares. Use short-term at the lowest effective dose and avoid ibuprofen if your clinician advises against NSAIDs. Seek urgent care if pain or redness is rapidly worsening.
Genetic influences
Most cases of Milroy disease are linked to a change in a gene called FLT4, which alters a growth signal (VEGFR3) that guides how lymph vessels form and function. Even with the same gene change, people can have very different amounts of swelling and different ages when symptoms first show up. Milroy disease often follows an autosomal dominant pattern—one altered copy is enough—so an affected parent has a 50% chance of passing it on to each child. In other families, it appears for the first time because of a new (de novo) gene change, with no prior family history. Genetic testing commonly looks for FLT4 changes and can confirm the diagnosis, though a small number of people with clear features of Milroy disease don’t have an identified change yet, suggesting other genes may be involved. This genetic basis helps explain why early symptoms of Milroy disease often appear at birth or in the first months of life, even though the course and severity can vary widely.
Is Milroy disease genetic?
Genetics is central in Milroy disease. Most cases result from inherited changes in the FLT4/VEGFR3 gene that disrupt lymphatic development; a single altered copy is enough. Variants can arise de novo, and severity can vary even within families.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and occur widely in the population. The majority do not directly influence health; they just reflect ordinary human diversity. In many genes, having a variant that has been associated with a condition signals a potential link, not a certain diagnosis, particularly when several genes and environmental influences play a role. That said, there are situations where one clearly defined variant in a particular gene is enough to make a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Milroy disease, inherited changes in the FLT4 gene shape the lymph system itself, so treatment usually centers on compression, skin care, and preventing infections rather than gene‑targeted drugs. When medications are used—for example, antibiotics for cellulitis or pain relievers—common drug–gene differences can still play a role. Genetic testing can sometimes identify how your body processes certain medications. For pain medicines like codeine or tramadol, some people process them too quickly or too slowly, which can lead to too little relief or more side effects; choosing a different option can help. In select centers, sirolimus may be tried for complex lymphatic complications, and its levels are affected by genes that influence liver enzymes, so close level monitoring is used even when pharmacogenetic testing isn’t done. There’s no approved therapy yet that directly targets the FLT4 change in Milroy disease, but genetics may guide future treatments and help tailor supportive medications for Milroy disease.
Interactions with other conditions
Living with Milroy disease, other health issues can make swelling and skin problems harder to manage day to day. A condition may “exacerbate” (make worse) symptoms of another. Diabetes, obesity, and chronic vein problems in the legs can all increase fluid buildup and slow healing, which raises the risk of cellulitis in Milroy disease. Skin conditions like athlete’s foot or eczema create tiny breaks in the skin that let bacteria in, so treating these promptly helps prevent recurrent infections. Heart or kidney disease can also cause leg swelling for different reasons, which can blur the picture and change how doctors approach treatment; some blood pressure medicines and other drugs are known to cause or worsen ankle swelling, so your care team may adjust medications if needed. Interactions can look very different from person to person, but coordinated care and early treatment of infections often reduce setbacks.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Milroy disease?
Swelling like in Milroy disease can also be caused by vein problems such as varicose veins or poor vein flow, a blood clot in a deep leg vein (deep vein thrombosis), or a skin infection like cellulitis that makes the area red, warm, and tender. It may also be mistaken for lipedema, a condition that causes a painful buildup of fat and fluid in both legs, or for fluid buildup from heart, kidney, or liver disease. In babies and children, certain birth vein and lymph vessel problems, including conditions where one leg grows larger with vein or skin changes, can look similar and need a specialist to sort out.
History
Families and communities once noticed patterns—newborns with puffy feet that never fully went away, relatives across generations sharing the same heavy swelling by the ankles. Midwives and doctors wrote about babies with tight, shiny skin over the tops of the feet, nails that grew differently, and swelling that seemed present from birth. These notes captured the day-to-day reality long before anyone knew why the fluid built up or how the lymph system was involved.
First described in the medical literature as a family form of lifelong leg swelling, later called Milroy disease, the condition stood out because it often began at or soon after birth and tended to run through multiple generations. Physicians observed that fathers, mothers, and their children could be affected in a recognizable pattern. Early reports emphasized what people noticed—persistent swelling, thicker skin, and occasional infections—without a clear map of the tiny vessels that normally drain fluid from the tissues.
As medical science evolved, researchers connected these symptoms to the lymphatic system, the body’s drainage network. Imaging studies, which became more available in the late 20th century, showed that some people with Milroy disease were born with fewer or smaller lymph vessels in the legs. This helped explain why the swelling was present so early and why it remained a lifelong feature for many.
Advances in genetics, especially in the late 1990s and early 2000s, provided a clearer explanation. Scientists identified changes in a gene important for forming lymph vessels, confirming that Milroy disease is an inherited form of primary lymphedema. This genetic insight matched what families had reported for generations and clarified why the condition could vary even within the same family—some had marked swelling from birth, while others had milder changes that appeared later.
In recent decades, awareness has grown around early symptoms of Milroy disease, such as swelling limited to the feet in infancy, subtle changes in toenails, and a heavier feeling in the legs after standing. Clinicians refined criteria to distinguish it from other causes of lymphedema that start later in childhood or adulthood. At the same time, care shifted from simply observing the swelling to proactive management, including compression strategies, skin care to reduce infection risk, and, in select cases, specialized procedures.
Over time, the way Milroy disease has been understood has changed, but the thread connecting past and present remains clear: careful observation by families and clinicians laid the groundwork for today’s diagnosis and care. Ongoing research continues to refine how we identify the condition early, support healthy growth in children, and tailor management so people with Milroy disease can stay active and comfortable.